316.24—Granting orphan-drug designation.
        
        (a) 
         FDA will grant the request for orphan-drug designation if none of the reasons described in  § 316.25 for requiring or permitting refusal to grant such a request applies.
    
    
        
        (b) 
         When a request for orphan-drug designation is granted, FDA will notify the sponsor in writing and will publicize the orphan-drug designation in accordance with  § 316.28.